Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE).

Fleischmann, Roy; Weinblatt, Michael; Ahmad, Harris; Maldonado, Michael A; Alemao, Evo; Ye, June; Schiff, Michael

Fleischmann, Roy; Weinblatt, Michael; Ahmad, Harris; Maldonado, Michael A; Alemao, Evo; Ye, June; Schiff, Michael.

Afiliação

Fleischmann R; University of Texas Southwestern Medical Center, Metroplex Clinical Research Center, Dallas, TX, USA. RFleischmann@arthdocs.com.
Weinblatt M; Brigham and Women's Hospital, Boston, MA, USA.
Ahmad H; Bristol-Myers Squibb, Princeton, NJ, USA.
Maldonado MA; Bristol-Myers Squibb, Princeton, NJ, USA.
Alemao E; Bristol-Myers Squibb, Princeton, NJ, USA.
Ye J; Bristol-Myers Squibb, Princeton, NJ, USA.
Schiff M; University of Colorado School of Medicine, Denver, CO, USA.

Rheumatol Ther ; 6(4): 559-571, 2019 Dec.

Article em En | MEDLINE | ID: mdl-31642045

Palavras-chave

DMARDs (biologic); Disease activity; Early rheumatoid arthritis; Rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google